维普期刊资源整合服务平台（V6.5）

132篇 您的检索式：作者名="STINCHCOMBE TE"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Annual review of advances in lung cancer clinical research:a report for the year2009显示文摘	Stinchcombe TE Bogart J Wigle DA	2010	J Thorac Oncol2010，5，7：	1
2	The dysfibrino- genaemias 显示文摘	Roberts HR Stinchcombe TE Gabriel DA	2001	Br J Haematol2001，114，2：	1
3	Current treatments for advanced stage non-small cell lung Cancer 显示文摘	Stinchcombe TE Socinski MA	2009	Proc Am Thorac Soc2009，6，2：	1
4	Renal cell carcinoma显示文摘	Godley PA Stinchcombe TE	1999	Curt Opin Oncol1999，11，3：	1
5	Considerations for second-line therapy of non-small cell lung cancer 显示文摘	Stinchcombe TE Socinski MA	2008	Oncologist2008，13，：	1
6	Combined modality therapy for stage Ⅲ non-small cell lung cancer 显示文摘	Stinchcombe TE Fried D Morris DE	2006	Oncologist2006，11，：	1
7	Renal cell carcinoma显示文摘	Godley PA Stinchcombe TE	1999	Curr Opin Oncol1999，11，：	1
8	Renal cell carcinoma显示文摘	Godley PA Stinchcombe TE	1999	Curr Opin Oncol1999，11，：	1
9	Personalized medicine in non-small cell lung cancer显示文摘	Roberts PJ Stinchcombe TE Der C J	2010	J Clin Oncol2010，28，31：	1
10	Considerations for second-line therapy of non-small cell lung cancer显示文摘	Stinchcombe TE Socinskl MA	2008	Oncologist2008，13，1：	1
11	Current approaches to advanced-stage non-small-cell lung cancer:first-line therapy in patients with a good functional status显示文摘	Stinchcombe TE Lee CB Socinski MA	2006	Clin Lung Cancer2006，7，4：	1
12	Induction chemotherapy with carboplatin, irinotecan, and paclitax- el followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage m A and stage m B non-small cell lung cancer显示文摘	Stinchcombe TE Morris DE Lee CB	2008	Journal of Thoracic Oncology2008，3，3：	1
13	Induction chemothera py with carboplatin,irinotecan,and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin,paclitaxel,and gefitinib in unresectable stage ⅢA and stage ⅢB non-small cell lung cancer显示文摘	Stinchcombe TE Morris DE Lee CB	2008	J Thorac Oncol2008，3，3：	1
14	Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies显示文摘	Orlowski RZ Stinchcombe TE Mitchell BS	2002	J Clin Oncol2002，20，22：	1
15	Treatment paradigms for advanced stage non-small cell lung cancer in the era of multiple lines of ther- apy显示文摘	Stinchcombe TE Socinski MA	2009	J Thorac Oncol2009，4，2：	1
16	Second-line therapy for advanced NSCLC显示文摘	Weiss JM Stinchcombe TE	2013	Oncologist2013，18，8：	1
17	Long-term follow-up of a phase Ⅰ/Ⅱ trial of dose escalating three-dimansional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage Ⅲ A/B non-small cell lung cancer显示文摘	Stinchcombe TE Lee CB Moore DT	2008	J Thorac Oncol2008，3，11：	1
18	Current approaches to advanced-stage non-small-cell lung cancer:first-line therapy in patients with a good functional status显示文摘	Stinchcombe TE Lee CB Socinski MA	2006	Clin Lung Cancer2006，7，4：	1
19	Personalized medicine in non small cell lung cancer显示文摘	RobeR PJ Stinchcombe TE Der CJ	2010	J Clin Oncol2010，28，31：	1
20	Considerations for second-line ther-apy of non-small cell lung cancer 显示文摘	Stinchcombe TE Socinski MA	2008	Oncologist2008，131，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示